Skip to content

Mechanisms of integration in psychedelic-assisted therapy

Nicole S. Coverdale, Douglas J. Cook

Journal of Military Veteran and Family Health December 1, 2023 DOI: 10.3138/jmvfh-2023-0014 via OpenAlex

Summary

AI-generated from the abstract

Psychedelic-assisted psychotherapy (PAP) combines psychedelic drugs with structured therapy in three phases: preparation, in-session support, and integration. A review of 17 randomized controlled trials using psychedelics for psychological conditions found that 16 used the PAP framework. Nineteen studies examined brain changes during the integration phase using MRI and psychological tools. Brain network changes were inconsistent across studies due to small sample sizes and varied methods, though some evidence suggests changes in the executive control network. Psychological changes related to cognitive flexibility and personality traits like openness and neuroticism. The authors recommend repeating studies with larger samples and additional MRI techniques.

Study at a glance

Characteristics Systematic review Randomized Peer reviewed
Keywords Psychotherapist Clinical psychology Neuroticism Openness to experience Randomized controlled trial
Citations 3
Key finding Changes in brain networks during the integration phase of psychedelic-assisted psychotherapy were inconsistent across studies, but some evidence suggests changes in the executive control network, and psychological changes were related to cognitive flexibility and personality traits such as openness and neuroticism.

Abstract

LAY SUMMARY Psychedelic pharmacotherapies combined with structured psychotherapy have shown promise in the treatment of several psychological conditions. This type of therapy is known as psychedelic-assisted psychotherapy (PAP) and includes three phases: preparation, in-session support, and integration. The purpose of this review was to identify randomized controlled trials (RCTs) that used psychedelics to treat a psychological condition and to summarize the literature on changes that may be associated with clinical outcomes, as measured with MRI and various psychologically based tools. Psychedelics were administered in 17 RCTs, and 16 of these did so within a PAP framework. A total of 19 studies were identified that looked at MRI or psychological outcomes during the integration phase. Changes in brain networks during integration were identified but were not consistent between studies because of small sample sizes and inconsistent methodology. Some evidence suggests that changes in the executive control network may occur after psychedelic administration. Psychological changes after psychedelic administration were related to cognitive flexibility and personality traits such as openness and neuroticism. Overall, studies in this field should be repeated with a greater number of participants and other MRI-based techniques.

Comments

No comments yet.

Log in to comment